Developmental aspects of the renal kallikrein-like activity in fetal and newborn lambs  by Robillard, Jean E. et al.
Kidney International, Vol. 22 (1982), pp. 594—601
Developmental aspects of the renal kallikrein-like activity
in fetal and newborn lambs
JEAN E. ROBILLARD, WILLIAM J. LAWTON, DOUGLAS N. WEISMANN,
and CHRISTINE SESSIONS
Departments of Pediatrics and Internal Medicine and the Cardiovascular Research Center, University of Iowa, Iowa City, Iowa
Developmental aspects of the renal kallikrein-like activity in fetal and
newborn lambs. The ontogeny of the renal kallikrein-like activity and
the interrelationships between this enzyme and the renin-angiotensin-
aldosterone and prostaglandin systems were studied in 43 chronically
catheterized sheep fetuses between 104 and 142 days of gestation (term,
145 days) and in 8 chronically catheterized newborn lambs between 5
and 23 days of age. Urinary kallikrein (UKal) excretion rate expressed
in absolute values (mEU/hr) or corrected for kidney weight (mEU hr
gKW') or glomerular filtration (mEU hC' ml GFR') increased
significantly during fetal maturation and after birth. The rise in UK1
during fetal and newborn life was not dependent on an increase in
urinary flow rate (r = —0.06). The increase in fetal UKaII (mEU hr
gKW1) correlated closely with the rise in plasma aldosterone concen-
tration for values above 35 pg/mI (r = 0.72, P < 0.001). A significant
negative correlation was found between UKaII (mEU . hr gKW I)
and log of individual urinary sodium excretion values (r = —0.78, P <
0.001). No correlation was found between UKaII and urinary prostaglan-
dins (PGE, PGF2,,) excretion during fetal and newborn life, but UKaIJ
correlated closely with the rise in renal blood flow during maturation (r
= 0.87, P < 0.001). The present data suggest that aldosterone is an
important regulator of UKaII release early during development. It is also
suggested that conceptional age is an important factor which may
modulate the renal sensitivity to aldosterone-stimulated UKaII
excretion.
Aspects ontogéniques de l'activité rénale kallikréine-like chez des
agneaux foetaux et nouveaux nés. L'ontogdnese de l'activité rénale de
type kallikréine et les inter-relations entre cette enzyme et le système
rCnine angiotensine-aldosterone et les prostaglandines ont étè étudiées
chez 43 foetus de mouton en preparation chronique, entre 104 et 142
jours de gestation (terme: 145 jours) et chez 8 agneaux nouveaux-nés en
preparation chronique entre 5 et 23 jours de vie. Le debit d'excrétion de
kallikréine urinaire (UKaII) exprimC en valeur absolue (mEU/hr) ou
corrigé pour le poids de rein (mEU hr gKW1) ou pour Ia filtration
glomerulaire (mEU hr . ml GFR1) s'est élevé significativement
pendant Ia maturation foetale et après la naissance. L'augmentation de
UKaII pendant Ia vie foetale et a Ia naissance n'était pas dépendante
d'une augmentation du debit urinaire (r = —0,06). L'augmentation de
UKaII foetale (mEU hr gKW') dtait étroitement corrélée avec
l'augmentation de Ia concentration d'aldostérone plasmatique pour des
valeurs au-dessus de 35 pg/mI (r 0,72, P < 0,001). Une correlation
negative significative a hté trouvhe entre UKaII (mEU Hr' gKWt) et
le logarithme de l'excrétion sodée urinaire individuelle (r = —0,78, P <
0,001). Aucune correlation n'a etC trouvée entre UKaI! et l'excretion de
prostaglandines urinaires (PGE, PGF2,) pendant Ia vie foetale et a Ia
naissance, mais UK,,Il Ctait étroitement corrClC avec l'augmentation do
debit sanguin renal pendant Ia maturation (r = 0,87, P < 0,001). Ces
données suggèrent que I'aldostérone est un facteur important dans Ia
regulation de Ia liberation de UKali pendant le dèveloppement precoce.
II est également suggere que l'age de conception est un important
facteur qui pourrait moduler Ia sensibilité rénale de l'excrétion de UKaII
stimulhe par l'aldostCrone.
The renin-angiotensin-aldosterone, the prostaglandin, and
the kallikrein-kinin systems are three major systems yielding
vasoactive hormones which may play a role in the regulation of
renal function and the control of blood pressure in the adult [1,
2]. Numerous complex interactions between these three sys-
tems have been described [3—5].
The activity of the renin-angiotensin-aldosterone system has
been found to be elevated in fetal and newborn animals when
compared to adult values [6]. Moreover, it has been shown that
this system can be stimulated during maturation in a manner
similar to the adult [7—101. It has also been demonstrated that
concentrations of PGE2 and metabolites of prostacyclin and
thromboxane are elevated in fetal urine [11, 12]. Furthermore,
we recently demonstrated that renal prostaglandins are impor-
tant modulators of renal vascular tone and renin secretion
during fetal life [13]. However, information about the ontogeny
of the renal kallikrein-kinin system and the interrelationships
between this system and the renin-angiotensin-aldosterone and
prostaglandin systems are lacking. On the other hand, there is
evidence that kinins may have a role to play as possible
mediators of circulatory changes during the transitional period
from fetal to newborn life [14—16].
This study was designed to investigate the developmental
aspects of the renal kallikrein-like activity and the possible
interrelationships between this enzyme and the renin-angioten-
sin-aldosterone and prostaglandin systems in fetal and newborn
lambs. Moreover, relationships between the kallikrein-kinin
system, renal circulatory changes, and sodium excretion during
development were investigated.
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Methods
Animal preparation and surgical procedures. The fetuses of
43 pregnant sheep of Dorset and Suffolk mixed breeding were
studied between 104 and 142 days of gestation (term, 145 days).
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Seventeen fetuses were between 104 and 119 days, 14 between
120 and 130 days, and 12 between 131 and 142 days. Gestational
ages were based on the induced ovulation technique as de-
scribed previously [17].
Anesthesia of the ewe and surgery of the fetus were per-
formed as described previously [13, 18]. Briefly, the pregnant
ewe was anesthetized using a mixture of 1% halothane, 33%
oxygen, and 66% nitrous oxide. The uterus was opened and
small catheters were inserted into the fetal femoral vein and
both femoral arteries. An additional catheter was placed in the
bladder via the urachus. A catheter was also secured in the
amniotic cavity for intrauterine pressure recording. Thereafter,
the fetal membranes, uterine cavity and abdominal wall were
closed in separate layers. All catheters were exteriorized
through a subcutaneous tunnel and placed in a cloth pouch on
the ewe's flank. Following surgery a recovery period of at least
6 days was required before performing experiments. Before the
start of each experiment, fetal weight was estimated according
to the following formula: fetal body wt (kg) = [0.096 x
gestational age (days)] — 9.223, (r = 0.85, P < 0.001) [18].
Eight newborn lambs between 5 and 23 days of postnatal age
were also studied. Surgery was performed in newborn lambs at
least 48 hr before the experiment. Under general anesthesia,
catheters were inserted in the femoral vein and superficial
femoral artery. An additional catheter was placed in the left
ventricle via the opposite superficial femoral artery for injection
of microspheres. A no. 4 French infant feeding tube was placed
in the bladder through a suprapubic incision. All catheters were
secured and tunnelled to exit the skin on the animal's flank. In
the first 6 hr of recovery, the animals were given 5% glucose
—0.25% saline solution intravenously until the animal was able
to feed by mouth. In all cases, the ewe accepted her postopera-
tive lamb and nursed the lamb adequately.
The pregnant and lactating ewes were given a mixture of
alfalfa and grain pellets. The diet was adjusted to deliver an
average of 2.8 mEq of sodium per kilogram of body weight
daily. The ewes were kept on this diet for at least 10 days before
performing experiments.
Physiologic studies. During the physiologic studies, the ewe
was transferred into a small cart that permitted it to stand only.
When newborn lambs were studied they were standing immobi-
lized in a harness. The glomerular filtration rate (GFR) in fetal
and newborn lambs was determined by a constant infusion of
['2511-sodium iothalamate (Iso-Tex, Friendswood, Texas) as
previously described [18]. A priming dose of iothalamate (0.45
Ci/kg) was administered to the fetus or newborn lamb fol-
lowed by a constant infusion of 0.1 Ci/kg/min in 5% dextrose
solution at a rate of 0.09 ml/min. An equilibration period of 1 hr
was allowed before the start of the first of two 30-mm renal
clearance periods. At the midpoint of each clearance period,
arterial blood was obtained for determinations of blood pH and
blood gases (Pco2 and Po2), plasma concentrations of [125Jj
sodium iothalamate, electrolytes (Nat, K, C1), angiotensin-
II (All) and aldosterone, plasma renin activity (PRA), and
hematocrit. Fetal blood samples were replaced with an equal
amount of maternal blood to avoid any hemodynamic effects of
sampling. In newborns, blood was replaced using an equal
volume of plasma protein fraction (Plasmanate, Cutter Labora-
tories, Berkeley, California).
Urine was collected for determinations of electrolytes (Na,
K, CL), ['251J-sodium iothalamate, prostaglandin (PGE and
PGF2), and kallikrein concentrations.
Renal blood flow was determined at the end of the urine
collection periods by infusing approximately 2.0 x 106 radioac-
tive microspheres (15 3 m diameter) labelled with either 85Sr
or 46Sc (3M Company, St. Paul, Minnesota). Microspheres
were infused in the inferior vena cava in fetuses and in the left
ventricle in newborn lambs as previously described [13, 18].
Blood for lower body independent reference sample was col-
lected from the femoral artery during a period of 3 mm
beginning 20 sec before the injection of microspheres and at a
withdrawal rate of 2.91 mI/mm using a Harvard infusion-
withdrawal pump.
Arterial and venous pressures were recorded continuously
using Statham P23Db pressure transducers (Statham Instru-
ments Division, Gould, Inc., Oxnard, California) and a Beck-
man R-61 1 recorder. In fetuses, mean arterial blood pressure
(MABP) readings were corrected relative to concomitant amni-
otic pressures. Heart rate was monitored with a cardiotachome-
ter triggered from the arterial pressure pulse wave.
Analytical methods. Blood for pH, Pco2 and P02 was collect-
ed anaerobically in heparinized glass syringes and measure-
ments were immediately determined with the appropriate pH,
Pco2 and Po2 electrodes using a Radiometer PHM 72 MK2 acid-
base analyzer (Radiometer Co., Copenhagen, Denmark). Plas-
ma and urinary electrolyte (Nat, K, C1) concentrations, and
concentrations of ['25I]-sodium iothalamate in plasma and urine
were determined as previously described [18].
Gamma emissions generated from the microspheres were
measured from fetal and newborn kidneys and from the refer-
ence femoral arterial blood samples. Immediately after the
kidneys had been removed from the animal, they were weighed,
cut into sagittal sections of less than 1 g, and placed in counting
vials containing a predetermined amount of 10% formalin in
such a way as to prevent air tissue interfaces that could alter the
counts. Energy window ranges were set between 210 to 275 keV
for 85Sr and 420 to 580 keV for 46Sc.
PRA and plasma aldosterone concentrations were deter-
mined by radioimmunoassays as described previously [19—21].
Blood samples for plasma Al! determinations were collected
in chilled tubes containing 0.3 M EDTA and 0.025 M 0-
phenanthroline. Thereafter, the cells and proteins were precip-
itated immediately with acetone 65% and the supernatant dried
under air for subsequent chromatographic isolation of All on
SP sephadex in sodium acetate buffer. All was then measured
by radioimmunoassay using the method previously described
by Catt, Baukal, and Asburn [22] and Cain, Coghian, and Catt
[231. The technique, reliability, and full characterization of this
assay in our laboratory have been reported previously [101.
Urine samples for prostaglandin determinations were collect-
ed under ice, then immediately frozen at —70°C. Urine samples
were extracted with ethylacetate and separated into classes by
silicic acid chromatography. The urinary PGE and PGF2a levels
were determined by radioimmunoassay using specific antisera.
The technique, reliability, and full characterization of each
assay have been reported previously [24, 251.
Urine samples for kallikrein determinations were collected
under ice, and NaN3 0.2% was used as a preservative. The
specimens were stored at —70°C. Before assaying for kallikrein
activity, urine samples were desalted on Sephadex G-25 col-
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the method of Spragg and Austen [301. The heated plasma had
neither kininase activity nor spontaneous kininogenase activity.
Specificity of the bioassay was determined by showing that
(1) neither the heated plasma (substrate) nor the HUK nor urine
sample alone had any oxytocic effect on the rat uterus and (2)
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Computations and data analysis. Renal blood flow (RBF),
0.049 . x
•
100 - renal vascular resistance (RVR), and filtration fraction (FF)
' 50 - •
were determined according to the following formula: RBF (ml!
mm) = total kidney counts x reference flow from the femoral
- 0 -
iii I
0 1000 2000 3000
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Fig. 1. Characterization of sheep urine [3H1-TAME esteras' activity,
Upper panel: DEAE-Sephadex A-50 chromatography separation (1.6 x
30 cm column) following pressure dialysis (—). Concentrated urine
was equilibrated with 0.2 M KCI to 0.01 M potassium phosphate buffer
(pH 7.0). The column was doted using a linear gradient 0.2 M KCL to
0.01 M potassium phosphate (pH 7.0) to 0.5 M KClto 0.01 M potassium
phosphate (pH 7.0) (----). One peak of esterase activity was eluted at a
conductivity corresponding to 0.34 M KCI to 0.1 M potassium phos-
phate. The dotted line (. , .) represents spectrophotometric absorption
at 280 mm. Lower panel: Relationship between sheep urine [3H]-TAME
esterase activity and generated bradykinin in presence of partially
purified sheep plasma kininogen without (—) and with (---) presence
of carboxypeptidase B (50 ng/ml).
artery (ml/min)/total femoral blood counts; RVR (mm Hg/mi!
mm) = RPP/RBF where RPP is the renal perfusion pressure
estimated to be equal to the aortic pressure minus the inferior
vena cava pressure; FF (%) = GFRIRPF where GFR and RPF
are milliliters per minute with RPF equal to RBF x (1-
,hematocrit
Statistical analysis of the data was performed using analysis
of variance and unpaired t test. When multiple comparisons
were done on the same group of data, the critical value oft was
.
corrected using the Bonferroni method [31]. Regression lines
and associated correlation coefficients were computed by the
least-squares formula. The term "significant" is used through-
out the paper to describe changes with a total P value of less
than 0.05 in a two-sided significance limit. The results are
presented as mean SEM.
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Results
Fetal arterial blood pH, Pco2, and Po2 values did not change
during the last trimester of gestation; the mean values were 7.37
0.01, 44.2 1.2, and 24.8 0,9 mm Hg, respectively. In
newborn lambs arterial blood pH, Pco2 and P02 were 7.42
0.02, 31.5 2.2, and 98.3 3.9 mm Hg, respectively. Plasma
sodium and potassium concentrations were 144 I and 4.29
0.11 mEq!liter, respectively, in fetuses. These levels were not
significantly different from values found in newborns (sodium
146 I mEq/liter and potassium 4.10 0.11 mEq!liter). Plasma
chloride concentration did not vary in fetuses during the last
trimester of gestation with the mean value of 103 1 mEq!liter.
This value was significantly lower than in newborn lambs (108
1 mEq/liter, P < 0.05).
Urinary kallikrein excretion during development. Values for
urinary kallikrein (UKaII) excretion rate are presented in Table
1. It is demonstrated that UKaii expressed in absolute values
(mEU/hr) or corrected for kidney weight (mEU 'hr gKW)
or GFR (mEU hr ml GFR1) increased significantly during
fetal maturation and after birth. Figure 2 demonstrates the
relationship between UKaII excretion rate (mEU hr gKW
and conceptional age. Prior to 120 days there were no signifi-
cant changes in UKall. However, during the 25 days that
preceded birth, UKail excretion rate increased as gestation
progressed. There was a significant correlation between UKaII
and conceptional age from 120 days to the time of birth (r =
0.70, P < 0.005). After birth, UKaII excretion rate was signifi-
cantly higher than during fetal life (Fig. 2 and Table 1) and
remained elevated up to 30 days postnatally.
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Table 1. Urinary kallikrein excretion rate in fetal and newborn lambsa
Urinary kallikrein excretion rate
mEU hr' mEU hr' g KW1 mEU hr ml GFR'
Fetuses
<120 days 58 10 (17) 3.3 0.5 (16) 29 5.1 (17)
120 to 130 days 142 27 (14)" 6.1 1.3 (9) 49 9.2 (14)
>130 days 320 72 (12)" 15.2 3.6 (7)b 89 19 (12)b
Newborn lambs 3195 870 (8)" 69.6 17.3 (6)" 157 36 (8)b
F 26.68 23.92 11.14
P <0.01 <0.01 <0.01
Abbreviations: F, values for the F distribution when the means of the four groups of animals are compared; KW, kidney weight; GFR,
glomerular filtration rate.
a Number in parentheses represents the number of animals studied. Values are means SEM.
"For P < 0.05 when values are compared to those found in fetuses <120 days.
For P < 0.05 when newborn values are compared to those found in fetuses >130 days.
Fetal period .a— Postnatal period —.-
150
plasma All (r = 0.64) and a low partial correlation when plasma
aldosterone was related to plasma potassium concentration (r =
0.26).
a Figure 3 demonstrates the relationship between UKaII excre-
tion rate (mEU hr' gKW') and plasma aldosterone
concentration. Urinary kallikrein did not rise during fetal life
when plasma aldosterone concentrations were below 35 pg/ml (r
= 0.24). However, significant rises in UKaIL were observed
when plasma aldosterone levels were above 35 pg/mI (r = 0.72,
P < 0.00 1) (Fig. 3). When the data were analyzed separately for
fetuses less than and over 120 days of gestation, no significant
correlation was found between plasma aldosterone and UKaII in
fetuses <120 days of gestation (r =
—0.11) whereas a highly
significant correlation was found for fetuses between 120 days
to 10 170 180 and term (r = 0.79, P < 0.001). Because of the small number of
animals no significant correlation was found between UKaII and
plasma aldosterone in newborn lambs. However, UKaII levels
tend to be higher in newborns than in fetuses for similar levels
of plasma aldosterone.
Developmental aspects of the renin-angiotensin-aldosterone
system and relationships with urinary kallikrein excretion rate
Values for PRA, plasma All, and plasma aldosterone concen-
trations are presented in Table 2. Significant increases in PRA
and plasma aldosterone concentration were found during the
last trimester of gestation and following birth. Plasma All
increased significantly after birth but no significant changes
were observed during the last trimester of gestation. However,
fetal individual values for PRA correlated closely with plasma
All concentration (r = 0.68, P < 0.001). Similarly, fetal plasma
aldosterone concentration correlated with fetal plasma All
levels (r = 0.63, P < 0.001). When values found in fetuses and
newborns were pooled, significant correlations were also found
between plasma All and PRA (r = 0.59, P < 0.001) and between
plasma All and plasma aldosterone concentrations (r = 0.79, P
< 0.001). Multiple regression analysis of plasma aldosterone,
plasma All, and plasma potassium concentrations demonstrat-
ed a high partial correlation between plasma aldosterone and
Relationships between urinary kallikrein excretion rate, renal
hemodynamics, and renal function during development
Renal function and RBF data are summarized in Tables 3 and
4, respectively. There was a significant increase in GFR (ml!
mm) and decreases in urinary excretion rate of sodium and
chloride during the last trimester of gestation and following
birth (Table 3). Urinary prostaglandin excretion (PGE and
PGF2a) did not change during fetal life but decreased signifi-
cantly after birth. These changes did not correlate significantly
with the rise in UKaII (mEU hr' gKW) during renal
development.
A significant decrease in renal vascular resistance (RVR) and
significant rises in RBF, FF, and MABP were observed in
newborn lambs (Table 4). During fetal life no significant
changes in RBF nor RVR were seen. However, there was a
significant correlation between fetal RBF and GFR values (r
0.65, P < 0.001); when values found in fetuses and newborns
were pooled, the coefficient of correlation was 0.93 (P < 0.001).
The rise in UKaII (mEU/hr) during fetal and newborn life
(Table 1) was not dependent on an increase in urinary flow rate
(mI/mm) (r = —0.06). However, a significant correlation be-
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Fig. 2. Relationship between urinary kallikrein (UKaI1) excretion rate
corrected for kidney weighi (KW) and conceptional age. The regression
line is calculated for fetuses from 120 days gestation to term (r = 0.70, P
< 0.05) (V = 0.724 X — 83.39).
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Fetuses • <120 days
£120 to 130 days
>130 days
Newborn lambs
35 50 100
Plasma aldosterone, pg/mi
Fig. 3. Relationship between urinary kallikrein (UK,,,) excretion rate
corrected for kidney weight (KW) and plasma aldosterone concentra-
tion. The open circle represents the mean value (±sEM) for plasma
aldosterone and UKaII in newborn lambs. The so/id line represents the
linear regression line for fetal plasma aldosterone levels above 35 pg/mi;
(y = 0.282 X — 5.75) (r = 0.72, P < 0.001).
tween UKaII (mEU hr gKW') and RBF (mi/mm) was found
(r = 0.87, P < 0.001; Fig. 4). Multiple regression analysis
among RBF, UKaII, MABP, and conceptional age demonstrated
that the rise in RBF during development correlated more
closely with the rise in UKaII than with either MABP or
conceptional age; the partial correlation coefficients were 0.70,
0.54, and 0.53, respectively.
The relationship between UKaII and sodium excretion was
also studied. When individual values for Ukall (mEU hr'
gKW 1) were plotted as a function of urinary sodium excretion
(UNaV) (p.Eq . min' ml GFR'), a linear regression of the
data showed a correlation coefficient of —0.44. However, the
data were best fit by plotting the log of individual UNa*V values
against UKaII (r = —0.78, P < 0.001; Fig. 5). A significant
correlation was also found between plasma aldosterone concen-
tration and log values for UNaV (r =
—0.73, P < 0.001).
Discussion
To our knowledge, this is the first study of renal kallikrein-
like activity in utero and in the postnatal period. The present
data show a significant increase in urinary kallikrein excretion
(UKaII) during the last part of the third trimester of pregnancy in
fetal lambs and a continued rise after birth (Fig. 2). In analogy
to the present results, it has been observed that the rate of
urinary kallikrein excretion in premature infants [32] is much
lower than levels observed later in life in normal children [33,
341.
This study also demonstrates that the increase in UKaII during
maturation is not dependent solely on an increase in renal mass
nor on a rise in GFR (Table I). Moreover, the changes seen in
UKaII do not correlate with changes in urinary flow rate.
Therefore, other factors may have been responsible for the
increase in UKaII during fetal and postnatal life.
Previous studies in adults have demonstrated that aldoster-
one is an important regulator of the release and/or the genera-
tion of renal kallikrein [3, 35]. In this study a significant
correlation is found between plasma aldosterone concentration
and UKlI excretion during fetal life when plasma aldosterone is
above 35 pglml. However, this relationship seems to be influ-
enced by the degree of fetal maturation. In fetuses <120 days of
gestation, there is no relationship between plasma aldosteronc
and UKaII (r —0.11), despite the fact that, in five fetuses,
plasma aldosterone concentration is above 35 pg/mI. In older
groups of fetuses, a close relationship is demonstrated between
plasma aldosterone and UKaII excretion (r = 0.79, P <0.001).
However, the level of UKaII achieved for similar plasma aldos-
terone concentration tends to be higher in the oldest group of
fetuses (>130 days gestation) than in fetuses between 120 to 130
days of gestation (Fig. 3). Similar results are seen when
newborn UKaII levels are compared to fetal levels. Taken
—j together these results suggest (1) that UKaII excretion rate is150 dependent on aldosterone during the last part of gestation and
following birth. (2) However, it is also suggested that aldoster-
one is not the only determinant of UK5II excretion in immature
animals, but that conceptional age is also an important factor
that may modulate the renal sensitivity to aldosterone-stimulat-
ed urinary kallikrein excretion. (3) Finally, it is possible that
during the postnatal period the rapid rise in arterial oxygen
tension may be an important stimulus for renal kallikrein as
previously suggested [36]; however, this study was not de-
signed to investigate this hypothesis.
In addition to the relationship observed between UKaH and
plasma aldosterone concentration, a significant negative corre-
lation is found between UKaI and log values for urinary sodium
excretion. This latter finding confirms the relationship between
UKaII and plasma aldosterone and suggests that urinary kalli-
krein may be a reliable index of sodium-retaining steroid
activity during development.
Relationships between the kallikrein-kinin and prostaglandin
systems have been described in adult animals [37]. Supporting
such a relationship, it has been demonstrated that renal arterial
infusion of bradykinin stimulates prostaglandin synthesis in the
kidney [38, 391, probably by activating enzymes which make
substrate available for prostaglandin synthetase [401. More
recently a similar interaction was suggested in children between
4 months and 14 years of age [34]. Contrary to these results, we
found no correlation between urinary kallikrein and urinary
prostaglandin excretion during fetal life. Moreover, prostaglan-
din excretion declines significantly following birth in newborn
lambs. Supporting these results, we have shown that infusion of
exogenous All does not increase urinary prostaglandin excre-
tion in fetal lambs, whereas significant rises are observed in
adult ewes [10]. Previous studies in humans also indicated a low
activity of the renal prostaglandin system after birth when
compared later in life [41—43].
Nevertheless, this decline in urinary prostagiandins is espe-
cially difficult to explain as plasma All and UKaII, two sub-
stances known to directly or indirectly stimulate renal prosta-
glandin production, increase rapidly after birth. However, one
may speculate that the rise in UKaII excretion during develop-
ment may not be associated with an increase in renal kinin
(bradykinin and lysyl-bradykinin) production which, in return,
would stimulate prostaglandin synthesis. Recent studies [40, 44]
have demonstrated that UKaII does not control kinin excretion
in normal subjects. Moreover, Abe et al [44] found a significant
negative correlation between UKaII excretion and urinary PGE
excretion in adult man. Also, the action of All and kinin on
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Table 2. Renin-angiotensin-aldosterone system in fetal and newborn 1ambs
Fetal lambs
born lambs F P<120 days 120 to 130 days >130 days New
PRA, ng/mi/hr 3.77 0.71 (17) 6.34 1.77 (14) 10.01 0.98 (12)" 16.60 4.75 (7)" 4.87 <0.01
All, pg/mI 32.3 3.33 (16) 32.8 3.05 (13) 41.1 5.77 (12) 150 28 (4)"' 37.19 <0.01
Aldosterone, pg/mi 31.7 3.07 (17) 37.2 4.65 (14) 58.6 7.66 (12)" 117 21 (7)b 18.65 <0.01
Abbreviations: F, values for the F distribution when the means of the four groups of animals are compared; PRA, plasma renin activity; All,
angiotensin II.
Number in parentheses represents the number of animals studied. Values are means SEM.
b For P < 0.05 when values are compared to values found in fetuses <120 days.
For P < 0.05 when newborn values are compared to values found in fetuses >130 days.
Table 3. Renal function data in fetal and newborn lambsa
Fetuses
Newborn lambs
N=8<120 daysN=17
120 to 130 days
N=14 >130 daysN=12
V. mI/mm
Cloth, mi/mm
Cioth, m1 min g KW
UNa*V, j.tEq min' ml GFR'
tEq . min ml GFR'
UK*V, p.Eq min' ml GFR'
UPGEV, ng min' g KW
UPGF,V, ng mm g KW
0.624 0.064
2.04 0.17
0.11 0.01
18.33 2.69
11.01 1.83
2.74 0.61
0.039 0.006
0.041 0.006
0.786 0.088
2.90 0.28
0.11 0.01
12.24 0.82
6.91 1.98
3.54 0.87
0.027 0.003
0.060 0.011
0.736 0.078
3.46 0.35"
0.13 0.02
8.90 1.92"
4.81 1.15"
3.28 0.71
0.035 0.011
0.065 0.009
0.428 0.095
21.80 5.19bc
0.39 0.07b.c
0.64 0.3l,c
0.93 0.37"
1.08 0.13
0.014 0.004"
0.019 0.005"
Abbreviations: V, urinary flow rate; Cioth, clearance of '251-sodium iothalamate as a measure of glomerular filtration rate (GFR); UV, urinary
excretion rate; KW, kidney weight; N, number of animals.
Values are means SEM.
b For P <0.05 when values are compared to values found in fetuses <120 days.
For P < 0.05 when newborn values are compared to values found in fetuses >130 days.
Table 4. Renal hemodynamics and arterial blood pressure values in fetal and newborn lambsa
Fetal lambs
born lambs F P<120 days 120 to 130 days >130 days New
RBF, m1 min' 42 4 (16) 44 3 (10) 50 5 (10) 175 27 (6)'.c 39.48 <0.01
mi min' g KW' 2.36 0.12 (16) 2.13 0.19 (10) 1.92 0.15 (10) 3.45 0.56 (6)" 5.92 <0.01
RVR, mm Hg m1' min 0.95 0.08 (16) 0.96 0.09 (10) 0.83 0.08 (10) 0.43 0.08 (6)c 6.08 <0.01
FF, % 6.8 0.4 (16) 8.4 0.7 (10) 10.6 1.5 (10)" 19.0 3.3 (6)" 13.90 <0.01
MABP, mm Hg 42 1 (17) 44 1 (14) 48 I (12)" 70 4 (8)"° 46.2 <0.01
Heart rate, beats/mm 178 4 (17) 161 5 (14) 152 5 (12)" 181 16 (8) 4.1 <0.05
Abbreviations: RBF, renal blood flow; RVR, renal vascular resistance; FF, filtration fraction; MABP, mean arterial blood pressure; F, values for
the F distribution when the mean values of the four groups of animals are compared.
Number in parentheses represents the number of animals studied. Values are means SEM.
For P < 0.05 when values are compared to values found in fetuses <120 days.
For P < 0.05 when newborn values are compared to values found in fetuses >130 days.
renal prostaglandin synthesis may have been inhibited by
endogenous hormones such as cortisone and hydrocortisone,
which have been shown to inhibit hormone-stimulated arachi-
donic acid release [40, 451. Plasma cortisol concentration is
elevated in neonates and the half-life of plasma cortisol is
prolonged significantly by adult standards [46]. Finally, it is
possible that a feedback mechanism between urinary kallikrein
and renal kinin production may indirectly affect renal prosta-
glandin production. Such a mechanism has been proposed
previously in man by Abe et al [44] but still remains to be
demonstrated during development.
This study also demonstrates that the rise in renal blood flow
during maturation is related closely to an increase in UKaII
excretion (Fig. 4). Previous studies in adult animals have found
a direct correlation between UKaII excretion rate and renal
blood flow [47, 481, suggesting a contribution by the kallikrein-
600 Robillard Ct a!
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Fig. 4. Relationship between renal blood flow (RBF) and urinary
kallikrein (UK,,) excretion rate corrected for kidney weight (KW).
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